We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Albemarle
ALB
$15.5B
| – | – |
-273,400
| Closed | -$35M |
|
1102
Alamo Group
ALG
$2.05B
| – | – |
-2,049
| Closed | -$231K |
|
1103
Altimmune
ALT
$599M
| – | – |
-1,786
| Closed | -$107K |
|
|
OSG
1104
Octave Specialty Group
OSG
$222M
| – | – |
-49,983
| Closed | -$799K |
|
1105
AMC Global Media
AMCX
$489M
| – | – |
-37,839
| Closed | -$2.05M |
|
1106
Amgen
AMGN
$222B
| – | – |
-97,000
| Closed | -$16.9M |
|
1107
AngioDynamics
ANGO
$649M
| – | – |
-207,669
| Closed | -$3.45M |
|
1108
Artisan Partners
APAM
$3.02B
| – | – |
-5,700
| Closed | -$225K |
|
1109
Air Products & Chemicals
APD
$67.6B
| – | – |
-60,806
| Closed | -$9.98M |
|
1110
Antero Resources
AR
$10.7B
| – | – |
-132,500
| Closed | -$2.52M |
|
1111
Aramark
ARMK
$14.7B
| – | – |
-309,833
| Closed | -$9.56M |
|
|
ASRT
1112
DELISTED
Assertio
ASRT
| – | – |
-272
| Closed | -$131K |
|
1113
ASE Group
ASX
$82.2B
| – | – |
-692,750
| Closed | -$4.49M |
|
1114
A10 Networks
ATEN
$1.95B
| – | – |
-11,900
| Closed | -$92K |
|
1115
Atkore
ATKR
$3.16B
| – | – |
-31,145
| Closed | -$668K |
|
1116
Broadcom
AVGO
$2.04T
| – | – |
-764,220
| Closed | -$19.6M |
|
1117
Azenta
AZTA
$1.48B
| – | – |
-771,244
| Closed | -$18.4M |
|
1118
Bath & Body Works
BBWI
$4.1B
| – | – |
-42,182
| Closed | -$2.05M |
|
1119
Brunswick
BC
$5.28B
| – | – |
-337,700
| Closed | -$18.6M |
|
1120
Barclays
BCS
$94.1B
| – | – |
-39,120
| Closed | -$408K |
|
1121
Becton Dickinson
BDX
$48.2B
| – | – |
-13,838
| Closed | -$2.89M |
|
1122
Franklin Resources
BEN
$17.2B
| – | – |
-878,588
| Closed | -$38.1M |
|
1123
Bright Horizons
BFAM
$3.86B
| – | – |
-13,634
| Closed | -$1.28M |
|
1124
Brown-Forman Class B
BF.B
$13.1B
| – | – |
-97,969
| Closed | -$4.31M |
|
1125
Bunge Global
BG
$20.8B
| – | – |
-88,232
| Closed | -$5.92M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.